Lynx Therapeutics Inc. and Genomics Collaborative Inc. join forces.
D001709:Biotechnology; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D004345:Drug Industry; D023281:Genomics; D006801:Humans; D011110:Polymorphism, Genetic